ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 201 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $158,892 | -12.3% | 27,827 | -29.3% | 0.12% | -17.3% |
| Q3 2023 | $181,074 | -48.5% | 39,364 | -27.7% | 0.14% | -39.8% |
| Q2 2023 | $351,521 | -2.4% | 54,415 | +14.0% | 0.23% | -8.3% |
| Q1 2023 | $359,982 | -27.0% | 47,743 | -2.0% | 0.25% | -38.5% |
| Q4 2022 | $493,000 | +1.4% | 48,693 | -0.9% | 0.41% | -0.5% |
| Q3 2022 | $486,000 | -8.0% | 49,144 | -0.9% | 0.41% | +240.5% |
| Q2 2022 | $528,000 | +59.0% | 49,591 | +45.8% | 0.12% | -46.0% |
| Q1 2022 | $332,000 | -17.6% | 34,013 | +20.8% | 0.22% | -17.6% |
| Q4 2021 | $403,000 | -16.9% | 28,167 | +16.5% | 0.27% | -18.8% |
| Q3 2021 | $485,000 | – | 24,188 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |